Q/C TECHNOLOGIES, INC. — Director's Dealing 2017

Oct 24, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Akers Biosciences, Inc. (AKER)
CIK: 0001321834
Period of Report: 2017-10-17

Reporting Person: Gormally John J (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-17	Common Stock	G	150000	$0.88	Acquired	180000	Direct

Footnotes

F1: On October 17, 2017, the Board of Directors of Akers Biosciences, Inc. approved the issuance of 150,000 restricted shares of common stock to the reporting person pursuant to the Akers Biosciences, Inc. 2017 Equity Incentive Plan.